Clinical trial

Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy

NCT03212755

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-08-01

PhaseNA

Study timeline

Study start (estimated)2017-08-01Date precision: month

Registry last updated2017-07-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathiesunresolved

Interventions

serum immunoglobulin G levelDIAGNOSTIC_TEST

Sponsors & collaborators

Assiut Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03212755 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.